List of GLP-1 agonists How GLP-1 Agonists Work Differently from GLP-1/Glucagon-like Peptide-1
We still need: Larger, long-term studies specifically focusing on psoriasis and PsA patients More data on optimal dosing and treatment duration Better understanding of how these drugs interact with current psoriasis and PsA treatments Empowering Your Psoriasis and PsA Management: Explore GLP-1 Options If you have psoriasis or PsA and struggle with weight management or treatment resistance, GLP-1 receptor agonists offer a new avenue for improving your condition
Not for human or animal use
Unwin N, Shaw J, Zimmet P, Alberti KGMM
Researchers to reveal trial results for dual agonism in type 1 diabetes Experts, including Klara Klein, MD, PhD, will discuss the possible benefits of a glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist (GLP-1/GIP RA) for people living with type 1 diabetes